Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INFLUENCE OF GUT MICROBIOTA ON THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS AND PERSONALIZATION OF DIABETES-LOWING THERAPY

NCT07627048 is registered in ClinicalTrials.gov with Pirogov Russian National Research Medical University as lead sponsor.

NCT NCT07627048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07627048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INFLUENCE OF GUT MICROBIOTA ON THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS AND PERSONALIZATION OF DIABETES-LOWING THERAPY
Lead sponsor
Pirogov Russian National Research Medical University
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
April 10, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes (t2dm)